Insight Molecular Diagnostics Inc. (IMDX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts IMDX Hot Sheet
Join SI Premium – FREE
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $470.85 thousand.
For earnings history and earnings-related data on Insight Molecular Diagnostics Inc. (IMDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
- Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
